Tang Qiang, Zhou Zili, Chen Jinhuang, Di Maojun, Ji Jintong, Yuan Wenzheng, Liu Zhengyi, Wu Liang, Zhang Xudan, Li Kang, Shu Xiaogang
Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Medicine (Baltimore). 2017 Dec;96(50):e9189. doi: 10.1097/MD.0000000000009189.
This article is aimed to retrospect the clinicopathological data of 2 cases of gastric MANENCs. MANEC is a rare biphasic tumor type that is coexistence of dual neuroendocrine and adenocarcinoma differentiation with each composing exceeding 30% volume. Gastric MANEC have just been reported anecdotally in the literature due to their rarity and heterogeneity. According to our study, these neoplasms have 3 different metastasis patterns: only adenocarcinomatous or neuroendocrine carcinoma and both of the 2 components. We first focus on the correlation of metastasis characteristics with prognosis in gastric MANEC, which may be potential implications for the choice of chemotherapy.
The 2 cases of patient shared several symptoms: epigastric discomfort, weight loss, hematemesis, or melena.
The 2 patients were diagnosis as MANEC based on the identification of histopathological analysis. In case 1, the poor differentiated adenocarcinoma accounted for 30%, the neuroendocrine part account for 70% and both of the 2 components metastasized to the lymph nodes, whereas in case 2, poorly differentiated adenocarcinoma accounted for 70%, the neuroendocrine part for 30% and only the glandular component invaded regional lymph nodes.
The first patient underwent laparoscopic radical gastrectomy and underwent adjuvant chemotherapy, combination of cisplatin, and etoposide successfully. The second patient received radical gastronomy, and did not receive any chemotherapy due to general weakness.
The first patient is alive with no evidence of recurrence, and the second patient died 6 months after the operation.
The assessment of metastatic sites should be a routine pathological practice, which is crucial for clinical decision-making and the selection of management.
本文旨在回顾2例胃混合性神经内分泌-腺癌(MANENCs)的临床病理资料。胃混合性神经内分泌-腺癌(MANEC)是一种罕见的双相肿瘤类型,由神经内分泌和腺癌分化成分共存,且每种成分体积超过30%。由于其罕见性和异质性,胃MANEC在文献中仅有零星报道。根据我们的研究,这些肿瘤有3种不同的转移模式:仅腺癌或神经内分泌癌转移以及两种成分均转移。我们首先关注胃MANEC转移特征与预后的相关性,这可能对化疗方案的选择有潜在意义。
2例患者有一些共同症状:上腹部不适、体重减轻、呕血或黑便。
根据组织病理学分析确诊为MANEC。病例1中,低分化腺癌占30%,神经内分泌部分占70%,两种成分均转移至淋巴结;而病例2中,低分化腺癌占70%,神经内分泌部分占30%,仅腺性成分侵犯区域淋巴结。
首例患者接受了腹腔镜根治性胃切除术,并成功接受了顺铂和依托泊苷联合辅助化疗。第二例患者接受了根治性胃切除术,因全身虚弱未接受任何化疗。
首例患者存活,无复发迹象;第二例患者术后6个月死亡。
转移部位的评估应作为常规病理检查,这对临床决策和治疗方案的选择至关重要。